FirstLook Lung is a blood-based test that helps identify lung cancer risk before or alongside LDCT, for USPSTF-eligible adults. From DELFI Diagnostics. Backed by Menlo.
About the role
In this contract role, you will be responsible for performing high complexity laboratory testing for cancer detection via next generation sequencing. You will work closely with automation, assay development and technology transfer scientists to build scalable infrastructure within the Clinical Laboratory. You will be part of a cross-functional team working to launch products for clinical use. Found on 1752vc Careers, the job board for startup and VC roles.
What they're looking for
- Perform laboratory tests, procedures, analyses, and reporting of patient results per approved procedures
- Identify and troubleshoot high complexity problems that may adversely affect the test performance
- Perform and document reagent manufacturing and qualification per approved procedures
- Verify instrument performance through inspection, calibration, and maintenance per approved procedures
- Organize and conduct the training of new and existing laboratory personnel on current and new procedures
More about this role
DELFI Diagnostics, Inc. (DELFI Diagnostics) is developing next-generation, blood-based tests that are reliable, accessible and deliver a new way to help detect cancer. Employing advanced machine-learning methods to whole-genome sequencing data, the DELFI ("DNA EvaLuation of Fragments for early Interception") platform is built to address the highest-burden health challenges. DELFI Diagnostics prioritizes solutions that have the potential to save lives on a global scale, including for historically underserved populations. DELFI Diagnostics’ platform relies on fragmentomics – the discovery that cancer cells are more chaotic than normal cells and, when they die, leave behind tell-tale patterns and characteristics of cell-free DNA (cfDNA) fragments. FirstLook Lung, for individuals eligible for lung cancer screening, is DELFI Diagnostics’ first laboratory-developed screening test and can be part of routine blood work. FirstLook Lung uses millions of data points to reliably identify individuals who may have cancer detected through low-dose CT, including early stage disease with a negative predictive value of 99.8 percent. This test has not been cleared or approved by the FDA.
In our...
Browse similar: Startup jobs · San Francisco Bay Area